OBJECTIVE: To analyze the immediate results and the clinical evolution of a group of fertile age @entity1 with @entity4794 , in whom percutaneous balloon mitral valvuloplasty was performed before or during pregnancy. @entity1 AND METHOD: Eighty-one @entity1 with @entity4794 , submitted to balloon mitral vavuloplasty, were studied. They were divided into three groups, according to their desire of no further pregnancies (group A; n = 19), pregnancy during the follow-up (group B; n = 23) or valvuloplasty was performed during pregnancy (group C; n = 39). @entity1 from group B and C were controlled during pregnancy, childbirth and puerperium, and the newborns of @entity1 in group C were followed from birth to the age of 5 years. RESULTS: Mortality in the three groups was null and the incidence of miscarriage was 2 (8.6%) in group B and 3 (9.1%) in group C. Normal delivery was predominant in group B and delivery by caesarean was predominant in group B. Success was immediate in all the cases. The procedure was repeated in 3 @entity1 due to restenosis. The media valvar area rase from 0.93 to 2.05 cm2 in group A, from 1.28 to 2.04 cm2 in group B and from 0.84 to 2.14 cm2 in group C (intergroup p = NS). The functional class improved in the three groups of @entity1 . CONCLUSION: Percutaneous balloon mitral valvuloplasty is an effective, efficient method for the treatment of @entity4794 during pregnancy, after organogenesis, or at any time in a @entity1 's life, as long as it is indicated according to clinical and echocardiographic evaluation criteria.

[The role of mitral valve balloon valvuloplasty in the treatment of rheumatic XXXX during pregnancy].

@entity1 :: ('9606', 'Species') :: ['women', 'Patients', 'woman', 'patients', 'PATIENTS'] @entity4794 :: ('MESH:D008946', 'Disease') :: ['rheumatic mitral stenosis', 'mitral stenosis']
@entity4794 :: (MESH:D008946,Disease) :: ['mitral valve stenosis']
